NIH Announces the Availability of Recovery Act Funds for Administrative Supplements
The National Institutes of Health (NIH) announces the opportunity for investigators and United States institutions/organizations with active NIH Research Grants to request administrative supplements for the purpose accelerating the tempo of scientific research on active grants.
Support for these supplements will come from funds provided to NIH through the American Recovery and Reinvestment Act of 2009 (?Recovery Act? or ?ARRA?), Public Law 111- 5. Consistent with the intent of the Recovery Act, the purpose of this program is to promote job creation and economic development along with accelerating the pace and achievement of scientific research.
In addition, Recovery Act funds allocated to NIH specifically for comparative effectiveness research (CER) may be available to support supplements.
Projects receiving these funds will need to meet this definition of CER:
?a rigorous evaluation of the impact of different options that are available for treating a given medical condition for a particular set of patients.
Such a study may compare similar treatments, such as competing drugs, or it may analyze very different approaches, such as surgery and drug therapy.? Such research may include the development and use of clinical registries, clinical data networks, and other forms of electronic health data that can be used to generate or obtain outcomes data as they apply to CER.
This announcement is one of three ARRA administrative supplement/competitive revision notices issued by NIH.
Approximately $1 billion of ARRA funds will be obligated by September 30, 2010 to support requests submitted in response to these three notices or any reissuance of these notices.
This administrative supplement solicitation requests submissions in all scientific and programmatic areas funded by NIH.
Support may be requested for up to 2 years for qualified grants (see eligibility section in full announcement).
Support for these supplements will come from funds provided to NIH through the American Recovery and Reinvestment Act of 2009 (?Recovery Act? or ?ARRA?), Public Law 111- 5. Consistent with the intent of the Recovery Act, the purpose of this program is to promote job creation and economic development along with accelerating the pace and achievement of scientific research.
In addition, Recovery Act funds allocated to NIH specifically for comparative effectiveness research (CER) may be available to support supplements.
Projects receiving these funds will need to meet this definition of CER:
?a rigorous evaluation of the impact of different options that are available for treating a given medical condition for a particular set of patients.
Such a study may compare similar treatments, such as competing drugs, or it may analyze very different approaches, such as surgery and drug therapy.? Such research may include the development and use of clinical registries, clinical data networks, and other forms of electronic health data that can be used to generate or obtain outcomes data as they apply to CER.
This announcement is one of three ARRA administrative supplement/competitive revision notices issued by NIH.
Approximately $1 billion of ARRA funds will be obligated by September 30, 2010 to support requests submitted in response to these three notices or any reissuance of these notices.
This administrative supplement solicitation requests submissions in all scientific and programmatic areas funded by NIH.
Support may be requested for up to 2 years for qualified grants (see eligibility section in full announcement).
Related Programs
TRANS-NIH RECOVERY ACT RESEARCH SUPPORT
Department of Health and Human ServicesNATIONAL CENTER FOR RESEARCH RESOURCES, RECOVERY ACT CONSTRUCTION SUPPORT
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: Not Available
Office: National Institutes of Health
Estimated Funding: Not Available
Who's Eligible
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-056.html
Additional Information of Eligibility:
This announcement is for administrative supplements to active NIH Research Grants and Research Program and Center Grants (Ps), as well as Career Development Awards (Ks), Institutional Training Grants (Ts), Cooperative Agreements (Us) and Educational Development Awards.
Individual NIH Institutes and Centers (ICs) have more detailed eligibility information on their own Web sites.
See http://grants.nih.gov/recovery/ic_supp.html.
Potential applicants should review the instructions for Revision Applications issued by their funding IC (See http://grants.nih.gov/recovery/ic_supp.html) before responding to this Notice.
Some ICs will consider administrative supplements only in target areas identified on their Web sites.
Note that NIH administrative supplements use paper PHS398 application forms.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-056.html
Contact:
NIH OER Webmaster
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
FBOWebmaster@OD.NIH.GOV
Date Posted:
2009-03-18
Application Due Date:
2009-04-21
Archive Date:
2010-10-30
Social Entrepreneurship
Spotlight
Rwanda as Social Entrepreneur Fund Beneficiary
The Republic of Rwanda has been picked as one of the six African countries as beneficiaries for a new fellowship fund program designed at supporting social entrepreneurs in tackling issues on food security.
Learn How to Identify and Avoid Grant Scams
